Global Axial Spondyloarthritis Treatment Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Axial Spondyloarthritis Treatment Revenue
1.4 Market by Type
1.4.1 Global Axial Spondyloarthritis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 COX-2 Antagonists
1.4.3 COX Inhibitors
1.4.4 Others
1.5 Market by Application
1.5.1 Global Axial Spondyloarthritis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Rehabilitation Center
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Axial Spondyloarthritis Treatment Market Perspective (2015-2026)
2.2 Global Axial Spondyloarthritis Treatment Growth Trends by Regions
2.2.1 Axial Spondyloarthritis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Axial Spondyloarthritis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Axial Spondyloarthritis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis
2.3.5 Axial Spondyloarthritis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Axial Spondyloarthritis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Axial Spondyloarthritis Treatment Players by Market Size
3.1.1 Global Top Axial Spondyloarthritis Treatment Players by Revenue (2015-2020)
3.1.2 Global Axial Spondyloarthritis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Axial Spondyloarthritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Axial Spondyloarthritis Treatment Market Concentration Ratio
3.2.1 Global Axial Spondyloarthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Axial Spondyloarthritis Treatment Revenue in 2019
3.3 Axial Spondyloarthritis Treatment Key Players Head office and Area Served
3.4 Key Players Axial Spondyloarthritis Treatment Product Solution and Service
3.5 Date of Enter into Axial Spondyloarthritis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Axial Spondyloarthritis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Axial Spondyloarthritis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Axial Spondyloarthritis Treatment Market Size by Application (2015-2020)
5.2 Global Axial Spondyloarthritis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Axial Spondyloarthritis Treatment Market Size (2015-2020)
6.2 Axial Spondyloarthritis Treatment Key Players in North America (2019-2020)
6.3 North America Axial Spondyloarthritis Treatment Market Size by Type (2015-2020)
6.4 North America Axial Spondyloarthritis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Axial Spondyloarthritis Treatment Market Size (2015-2020)
7.2 Axial Spondyloarthritis Treatment Key Players in Europe (2019-2020)
7.3 Europe Axial Spondyloarthritis Treatment Market Size by Type (2015-2020)
7.4 Europe Axial Spondyloarthritis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Axial Spondyloarthritis Treatment Market Size (2015-2020)
8.2 Axial Spondyloarthritis Treatment Key Players in China (2019-2020)
8.3 China Axial Spondyloarthritis Treatment Market Size by Type (2015-2020)
8.4 China Axial Spondyloarthritis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Axial Spondyloarthritis Treatment Market Size (2015-2020)
9.2 Axial Spondyloarthritis Treatment Key Players in Japan (2019-2020)
9.3 Japan Axial Spondyloarthritis Treatment Market Size by Type (2015-2020)
9.4 Japan Axial Spondyloarthritis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Axial Spondyloarthritis Treatment Market Size (2015-2020)
10.2 Axial Spondyloarthritis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Axial Spondyloarthritis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Axial Spondyloarthritis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Axial Spondyloarthritis Treatment Market Size (2015-2020)
11.2 Axial Spondyloarthritis Treatment Key Players in India (2019-2020)
11.3 India Axial Spondyloarthritis Treatment Market Size by Type (2015-2020)
11.4 India Axial Spondyloarthritis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Axial Spondyloarthritis Treatment Market Size (2015-2020)
12.2 Axial Spondyloarthritis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Axial Spondyloarthritis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Axial Spondyloarthritis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 UCB Biosciences
13.1.1 UCB Biosciences Company Details
13.1.2 UCB Biosciences Business Overview
13.1.3 UCB Biosciences Axial Spondyloarthritis Treatment Introduction
13.1.4 UCB Biosciences Revenue in Axial Spondyloarthritis Treatment Business (2015-2020))
13.1.5 UCB Biosciences Recent Development
13.2 Pfizer
13.2.1 Pfizer Company Details
13.2.2 Pfizer Business Overview
13.2.3 Pfizer Axial Spondyloarthritis Treatment Introduction
13.2.4 Pfizer Revenue in Axial Spondyloarthritis Treatment Business (2015-2020)
13.2.5 Pfizer Recent Development
13.3 Abbott Pharmaceuticals
13.3.1 Abbott Pharmaceuticals Company Details
13.3.2 Abbott Pharmaceuticals Business Overview
13.3.3 Abbott Pharmaceuticals Axial Spondyloarthritis Treatment Introduction
13.3.4 Abbott Pharmaceuticals Revenue in Axial Spondyloarthritis Treatment Business (2015-2020)
13.3.5 Abbott Pharmaceuticals Recent Development
13.4 Merck Sharp & Dohme
13.4.1 Merck Sharp & Dohme Company Details
13.4.2 Merck Sharp & Dohme Business Overview
13.4.3 Merck Sharp & Dohme Axial Spondyloarthritis Treatment Introduction
13.4.4 Merck Sharp & Dohme Revenue in Axial Spondyloarthritis Treatment Business (2015-2020)
13.4.5 Merck Sharp & Dohme Recent Development
13.5 GlaxoSmithKline
13.5.1 GlaxoSmithKline Company Details
13.5.2 GlaxoSmithKline Business Overview
13.5.3 GlaxoSmithKline Axial Spondyloarthritis Treatment Introduction
13.5.4 GlaxoSmithKline Revenue in Axial Spondyloarthritis Treatment Business (2015-2020)
13.5.5 GlaxoSmithKline Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of TablesTable 1. Axial Spondyloarthritis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Axial Spondyloarthritis Treatment Revenue
Table 3. Ranking of Global Top Axial Spondyloarthritis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Axial Spondyloarthritis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of COX-2 Antagonists
Table 6. Key Players of COX Inhibitors
Table 7. Key Players of Others
Table 8. Global Axial Spondyloarthritis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Axial Spondyloarthritis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Axial Spondyloarthritis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Axial Spondyloarthritis Treatment Market Share by Regions (2015-2020)
Table 12. Global Axial Spondyloarthritis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Axial Spondyloarthritis Treatment Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Axial Spondyloarthritis Treatment Market Growth Strategy
Table 18. Main Points Interviewed from Key Axial Spondyloarthritis Treatment Players
Table 19. Global Axial Spondyloarthritis Treatment Revenue by Players (2015-2020) (Million US$)
Table 20. Global Axial Spondyloarthritis Treatment Market Share by Players (2015-2020)
Table 21. Global Top Axial Spondyloarthritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Axial Spondyloarthritis Treatment as of 2019)
Table 22. Global Axial Spondyloarthritis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Axial Spondyloarthritis Treatment Product Solution and Service
Table 25. Date of Enter into Axial Spondyloarthritis Treatment Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Axial Spondyloarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 28. Global Axial Spondyloarthritis Treatment Market Size Share by Type (2015-2020)
Table 29. Global Axial Spondyloarthritis Treatment Revenue Market Share by Type (2021-2026)
Table 30. Global Axial Spondyloarthritis Treatment Market Size Share by Application (2015-2020)
Table 31. Global Axial Spondyloarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 32. Global Axial Spondyloarthritis Treatment Market Size Share by Application (2021-2026)
Table 33. North America Key Players Axial Spondyloarthritis Treatment Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Axial Spondyloarthritis Treatment Market Share (2019-2020)
Table 35. North America Axial Spondyloarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 36. North America Axial Spondyloarthritis Treatment Market Share by Type (2015-2020)
Table 37. North America Axial Spondyloarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 38. North America Axial Spondyloarthritis Treatment Market Share by Application (2015-2020)
Table 39. Europe Key Players Axial Spondyloarthritis Treatment Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Axial Spondyloarthritis Treatment Market Share (2019-2020)
Table 41. Europe Axial Spondyloarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Axial Spondyloarthritis Treatment Market Share by Type (2015-2020)
Table 43. Europe Axial Spondyloarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Axial Spondyloarthritis Treatment Market Share by Application (2015-2020)
Table 45. China Key Players Axial Spondyloarthritis Treatment Revenue (2019-2020) (Million US$)
Table 46. China Key Players Axial Spondyloarthritis Treatment Market Share (2019-2020)
Table 47. China Axial Spondyloarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 48. China Axial Spondyloarthritis Treatment Market Share by Type (2015-2020)
Table 49. China Axial Spondyloarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 50. China Axial Spondyloarthritis Treatment Market Share by Application (2015-2020)
Table 51. Japan Key Players Axial Spondyloarthritis Treatment Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Axial Spondyloarthritis Treatment Market Share (2019-2020)
Table 53. Japan Axial Spondyloarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Axial Spondyloarthritis Treatment Market Share by Type (2015-2020)
Table 55. Japan Axial Spondyloarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Axial Spondyloarthritis Treatment Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Axial Spondyloarthritis Treatment Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Axial Spondyloarthritis Treatment Market Share (2019-2020)
Table 59. Southeast Asia Axial Spondyloarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Axial Spondyloarthritis Treatment Market Share by Type (2015-2020)
Table 61. Southeast Asia Axial Spondyloarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Axial Spondyloarthritis Treatment Market Share by Application (2015-2020)
Table 63. India Key Players Axial Spondyloarthritis Treatment Revenue (2019-2020) (Million US$)
Table 64. India Key Players Axial Spondyloarthritis Treatment Market Share (2019-2020)
Table 65. India Axial Spondyloarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 66. India Axial Spondyloarthritis Treatment Market Share by Type (2015-2020)
Table 67. India Axial Spondyloarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 68. India Axial Spondyloarthritis Treatment Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Axial Spondyloarthritis Treatment Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Axial Spondyloarthritis Treatment Market Share (2019-2020)
Table 71. Central & South America Axial Spondyloarthritis Treatment Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Axial Spondyloarthritis Treatment Market Share by Type (2015-2020)
Table 73. Central & South America Axial Spondyloarthritis Treatment Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Axial Spondyloarthritis Treatment Market Share by Application (2015-2020)
Table 75. UCB Biosciences Company Details
Table 76. UCB Biosciences Business Overview
Table 77. UCB Biosciences Product
Table 78. UCB Biosciences Revenue in Axial Spondyloarthritis Treatment Business (2015-2020) (Million US$)
Table 79. UCB Biosciences Recent Development
Table 80. Pfizer Company Details
Table 81. Pfizer Business Overview
Table 82. Pfizer Product
Table 83. Pfizer Revenue in Axial Spondyloarthritis Treatment Business (2015-2020) (Million US$)
Table 84. Pfizer Recent Development
Table 85. Abbott Pharmaceuticals Company Details
Table 86. Abbott Pharmaceuticals Business Overview
Table 87. Abbott Pharmaceuticals Product
Table 88. Abbott Pharmaceuticals Revenue in Axial Spondyloarthritis Treatment Business (2015-2020) (Million US$)
Table 89. Abbott Pharmaceuticals Recent Development
Table 90. Merck Sharp & Dohme Company Details
Table 91. Merck Sharp & Dohme Business Overview
Table 92. Merck Sharp & Dohme Product
Table 93. Merck Sharp & Dohme Revenue in Axial Spondyloarthritis Treatment Business (2015-2020) (Million US$)
Table 94. Merck Sharp & Dohme Recent Development
Table 95. GlaxoSmithKline Company Details
Table 96. GlaxoSmithKline Business Overview
Table 97. GlaxoSmithKline Product
Table 98. GlaxoSmithKline Revenue in Axial Spondyloarthritis Treatment Business (2015-2020) (Million US$)
Table 99. GlaxoSmithKline Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Axial Spondyloarthritis Treatment Market Share by Type: 2020 VS 2026
Figure 2. COX-2 Antagonists Features
Figure 3. COX Inhibitors Features
Figure 4. Others Features
Figure 5. Global Axial Spondyloarthritis Treatment Market Share by Application: 2020 VS 2026
Figure 6. Hospital Case Studies
Figure 7. Rehabilitation Center Case Studies
Figure 8. Other Case Studies
Figure 9. Axial Spondyloarthritis Treatment Report Years Considered
Figure 10. Global Axial Spondyloarthritis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Axial Spondyloarthritis Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Axial Spondyloarthritis Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Axial Spondyloarthritis Treatment Market Share by Players in 2019
Figure 15. Global Top Axial Spondyloarthritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Axial Spondyloarthritis Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Axial Spondyloarthritis Treatment Revenue in 2019
Figure 17. North America Axial Spondyloarthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Axial Spondyloarthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Axial Spondyloarthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Axial Spondyloarthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Axial Spondyloarthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Axial Spondyloarthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Axial Spondyloarthritis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed